Angiotech Pharmaceuticals to participate in Lehman Brothers Conference
24 März 2005 - 9:00PM
PR Newswire (US)
Angiotech Pharmaceuticals to participate in Lehman Brothers
Conference VANCOUVER, March 24 /PRNewswire-FirstCall/ -- Angiotech
Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), is
scheduled to participate in the Lehman Brothers 8th Annual
Healthcare Conference. William Hunter, President and CEO of
Angiotech, will be making a 25-minute presentation at the
conference on Wednesday, March 30th, 2005 at 10:15 am EST (7:15 am
PST). A live webcast of Dr. Hunter's remarks will be available to
all interested parties at Angiotech's website at
http://www.angiotech.com/ in the Investor Relations section. To
ensure a timely connection to the webcast, it is recommended that
users register at least 15 minutes before the webcast begins.
Vancouver-based Angiotech Pharmaceuticals, Inc., a specialty
pharmaceutical company focusing on drug-coated medical devices and
biomaterials, is dedicated to enhancing the performance of medical
devices and biomaterials through the innovative uses of
pharmacotherapeutics. To find out more about Angiotech
Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), please
visit our website at http://www.angiotech.com/. CONTACTS: Todd
Young, Angiotech Pharmaceuticals (Analysts & Investors) (604)
221-7676 ext 6933 Rui Avelar, Angiotech Pharmaceuticals, Inc.
(Analysts) (604) 221-7676 ext 6996 Eric Starkman, Starkman &
Associates (Media) (212) 252-8545 ext 12 DATASOURCE: Angiotech
Pharmaceuticals, Inc. CONTACT: Todd Young, Angiotech
Pharmaceuticals (Analysts & Investors), (604) 221-7676 ext
6933; Rui Avelar, Angiotech Pharmaceuticals, Inc. (Analysts), (604)
221-7676 ext 6996; Eric Starkman, Starkman & Associates
(Media), (212) 252-8545 ext 12
Copyright
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals (MM) News-Artikel